NIH-funded research R01 grant

Immune changes linked to depression during perimenopause

Official title: The immunobiological mechanisms of depression in perimenopause

Funded at Van Andel Research Institute · NIH-11250128 · Data updated 2026-11-12

This project looks at how hormone-related immune changes may cause depression in women going through perimenopause.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startDecember 20, 2024
Project endNovember 30, 2029
Funding year2026
Award (this year)$765,613
NIH project number5R01MH139201-02
Project IDNIH-11250128 on NIH RePORTER

Who could benefit from this research

Could help

Women who are in the perimenopausal transition, especially those with current depressive symptoms or a history of depression, are the most likely candidates.

Less likely to help

People who are not in perimenopause (men, younger premenopausal women, or those long past menopause) are unlikely to benefit directly from this specific work.

What this research studies

If you join, researchers will collect blood and clinical information from women in perimenopause, including those with and without depressive symptoms. They will examine immune cells (especially T cells), measure cytokines and tryptophan-related metabolites, and analyze DNA methylation and chromatin accessibility using methods such as ATAC-seq. By comparing these molecular patterns to symptoms and hormone changes, the team hopes to identify immune pathways that shift during the menopause transition. Results could point to blood markers or immune-targeted approaches to reduce depression risk in this time of life.

Why it matters

Potential benefit: Could help identify biomarkers or immune targets that lead to new ways to prevent or treat depression during perimenopause.

How similar studies have gone: Prior work has linked immune and tryptophan-metabolite changes to depression in pregnancy and postpartum, but applying this immune- and chromatin-focused approach to perimenopause is relatively new.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Brundin, Lena Cecilia — Van Andel Research Institute
  • Study coordinator: Brundin, Lena Cecilia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.